Serine 129 Phosphorylation Reduces The Ability Of Alpha-Synuclein To Regulate Tyrosine Hydroxylase And Protein Phosphatase 2a In Vitro And In Vivo

Haiyan Lou,Susana E. Montoya,Tshianda N. M. Alerte,Jian Wang,Jianjun Wu,Xiangmin Peng,Chang-Sook Hong,Emily E. Friedrich,Samantha A. Mader,Courtney J. Pedersen,Brian S. Marcus,Alison L. Mccormack,Donato A. Di Monte,S. Colette Daubner,Ruth G. Perez

DOI: https://doi.org/10.1074/jbc.M110.100867

IF: 5.485

2010-01-01

Journal of Biological Chemistry

Abstract:alpha-Synuclein (a-Syn), a protein implicated in Parkinson disease, contributes significantly to dopamine metabolism. a-Syn binding inhibits the activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. Phosphorylation of TH stimulates its activity, an effect that is reversed by protein phosphatase 2A (PP2A). In cells, a-Syn overexpression activates PP2A. Here we demonstrate that a-Syn significantly inhibited TH activity in vitro and in vivo and that phosphorylation of a-Syn serine 129 (Ser-129) modulated this effect. In MN9D cells, a-Syn overexpression reduced TH serine 19 phosphorylation (Ser(P)-19). In dopaminergic tissues from mice overexpressing human a-Syn in catecholamine neurons only, TH-Ser-19 and TH-Ser-40 phosphorylation and activity were also reduced, whereas PP2A was more active. Cerebellum, which lacks excess a-Syn, had PP2A activity identical to controls. Conversely, a-Syn knock-out mice had elevated TH-Ser-19 phosphorylation and activity and less active PP2A in dopaminergic tissues. Using an a-Syn Ser-129 dephosphorylation mimic, with serine mutated to alanine, TH was more inhibited, whereas PP2A was more active in vitro and in vivo. Phosphorylation of a-Syn Ser-129 by Polo-like-kinase 2 in vitro reduced the ability of a-Syn to inhibit TH or activate PP2A, identifying a novel regulatory role for Ser-129 on a-Syn. These findings extend our understanding of normal a-Syn biology and have implications for the dopamine dysfunction of Parkinson disease.